nodes	percent_of_prediction	percent_of_DWPC	metapath
Midodrine—CYP2D6—Parkinson's disease	0.879	1	CbGaD
Midodrine—Melatonin—NQO2—Parkinson's disease	0.00814	1	CrCbGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000147	0.0013	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—PENK—Parkinson's disease	0.000147	0.0013	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—TAC1—Parkinson's disease	0.000146	0.0013	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—DRD1—Parkinson's disease	0.000144	0.00127	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—GRK5—Parkinson's disease	0.000143	0.00127	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—GRM4—Parkinson's disease	0.000141	0.00125	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—GRK5—Parkinson's disease	0.00014	0.00124	CbGpPWpGaD
Midodrine—SLC15A1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	0.00014	0.00124	CbGpPWpGaD
Midodrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000139	0.00123	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—DRD3—Parkinson's disease	0.000139	0.00123	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.000139	0.00123	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—GRM5—Parkinson's disease	0.000137	0.00121	CbGpPWpGaD
Midodrine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000135	0.00119	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—VPS35—Parkinson's disease	0.000135	0.00119	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—DGKQ—Parkinson's disease	0.000134	0.00119	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GPR37—Parkinson's disease	0.000134	0.00119	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—PDYN—Parkinson's disease	0.000134	0.00119	CbGpPWpGaD
Midodrine—SLC15A1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	0.000134	0.00119	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PENK—Parkinson's disease	0.000134	0.00119	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000132	0.00117	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—HTR1A—Parkinson's disease	0.000132	0.00117	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—TAC1—Parkinson's disease	0.00013	0.00115	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—GRM4—Parkinson's disease	0.000128	0.00114	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—DRD1—Parkinson's disease	0.000128	0.00113	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—GRK5—Parkinson's disease	0.000127	0.00112	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—DRD2—Parkinson's disease	0.000126	0.00111	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—HTR7—Parkinson's disease	0.000126	0.00111	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—GRM4—Parkinson's disease	0.000125	0.00111	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—GRM5—Parkinson's disease	0.000125	0.0011	CbGpPWpGaD
Midodrine—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.000124	0.0011	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—DRD3—Parkinson's disease	0.000124	0.00109	CbGpPWpGaD
Midodrine—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.000123	0.00109	CbGpPWpGaD
Midodrine—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.000123	0.00109	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000123	0.00109	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—PDYN—Parkinson's disease	0.000122	0.00108	CbGpPWpGaD
Midodrine—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000122	0.00108	CbGpPWpGaD
Midodrine—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000122	0.00108	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PENK—Parkinson's disease	0.000122	0.00108	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—EDN1—Parkinson's disease	0.000121	0.00107	CbGpPWpGaD
Midodrine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00012	0.00106	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—VPS35—Parkinson's disease	0.00012	0.00106	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PENK—Parkinson's disease	0.000119	0.00105	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000117	0.00104	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000117	0.00103	CbGpPWpGaD
Midodrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000116	0.00102	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—GRM4—Parkinson's disease	0.000114	0.00101	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—GRM5—Parkinson's disease	0.000114	0.00101	CbGpPWpGaD
Midodrine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	0.000113	0.001	CbGpPWpGaD
Midodrine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000112	0.000991	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—DRD2—Parkinson's disease	0.000112	0.000989	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—HTR7—Parkinson's disease	0.000112	0.000989	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GPR37—Parkinson's disease	0.000111	0.000987	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—DGKQ—Parkinson's disease	0.000111	0.000987	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—PDYN—Parkinson's disease	0.000111	0.000985	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—PDYN—Parkinson's disease	0.000109	0.000963	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PENK—Parkinson's disease	0.000108	0.000956	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—RIT2—Parkinson's disease	0.000107	0.00095	CbGpPWpGaD
Midodrine—ADRA1D—GPCR ligand binding—HTR2A—Parkinson's disease	0.000106	0.000939	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—ADORA2A—Parkinson's disease	0.000106	0.000938	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—GRM5—Parkinson's disease	0.000103	0.000915	CbGpPWpGaD
Midodrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000103	0.000909	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000102	0.000903	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GRK5—Parkinson's disease	0.000102	0.000901	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—HTR1A—Parkinson's disease	0.000101	0.000896	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—GRM5—Parkinson's disease	0.000101	0.000895	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—EDN1—Parkinson's disease	0.000101	0.000891	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—TAC1—Parkinson's disease	9.97e-05	0.000882	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—DGKQ—Parkinson's disease	9.9e-05	0.000877	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GPR37—Parkinson's disease	9.9e-05	0.000877	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—PDYN—Parkinson's disease	9.88e-05	0.000875	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—DRD1—Parkinson's disease	9.78e-05	0.000865	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—ADORA2A—Parkinson's disease	9.68e-05	0.000857	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—DRD3—Parkinson's disease	9.47e-05	0.000838	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—HTR1A—Parkinson's disease	9.19e-05	0.000814	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—GRM5—Parkinson's disease	9.19e-05	0.000813	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GRM4—Parkinson's disease	9.13e-05	0.000808	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PPP1R1B—Parkinson's disease	9.06e-05	0.000802	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—TAC1—Parkinson's disease	9.05e-05	0.000801	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—EDN1—Parkinson's disease	8.94e-05	0.000792	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—RIT2—Parkinson's disease	8.91e-05	0.000789	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—DRD1—Parkinson's disease	8.88e-05	0.000786	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—ADRBK1—Parkinson's disease	8.84e-05	0.000783	CbGpPWpGaD
Midodrine—ADRA1B—GPCR ligand binding—HTR2A—Parkinson's disease	8.81e-05	0.00078	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—ADORA2A—Parkinson's disease	8.79e-05	0.000778	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PENK—Parkinson's disease	8.66e-05	0.000766	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MAG—Parkinson's disease	8.66e-05	0.000766	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—ADORA2A—Parkinson's disease	8.6e-05	0.000761	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—DRD3—Parkinson's disease	8.6e-05	0.000761	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—HTR7—Parkinson's disease	8.56e-05	0.000758	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—DRD2—Parkinson's disease	8.56e-05	0.000758	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GRK5—Parkinson's disease	8.45e-05	0.000748	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—HTR1A—Parkinson's disease	8.4e-05	0.000744	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—TAC1—Parkinson's disease	8.27e-05	0.000732	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—DRD1—Parkinson's disease	8.11e-05	0.000718	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ND3—Parkinson's disease	8.04e-05	0.000712	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	8.04e-05	0.000712	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—ADRBK1—Parkinson's disease	8.03e-05	0.000711	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—RIT2—Parkinson's disease	7.92e-05	0.000701	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—PDYN—Parkinson's disease	7.92e-05	0.000701	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—DRD3—Parkinson's disease	7.86e-05	0.000696	CbGpPWpGaD
Midodrine—ADRA1A—GPCR ligand binding—HTR2A—Parkinson's disease	7.82e-05	0.000692	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—ADORA2A—Parkinson's disease	7.81e-05	0.000691	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—DRD2—Parkinson's disease	7.78e-05	0.000688	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—HTR7—Parkinson's disease	7.78e-05	0.000688	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—HTR1A—Parkinson's disease	7.63e-05	0.000675	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GRM4—Parkinson's disease	7.58e-05	0.000671	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—OMD—Parkinson's disease	7.56e-05	0.000669	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	7.56e-05	0.000669	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—TAC1—Parkinson's disease	7.51e-05	0.000665	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GRK5—Parkinson's disease	7.51e-05	0.000664	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—HTR1A—Parkinson's disease	7.46e-05	0.000661	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GFAP—Parkinson's disease	7.44e-05	0.000659	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—DRD1—Parkinson's disease	7.37e-05	0.000652	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—GRM5—Parkinson's disease	7.36e-05	0.000651	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—TAC1—Parkinson's disease	7.35e-05	0.00065	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—ADRBK1—Parkinson's disease	7.34e-05	0.000649	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—DRD1—Parkinson's disease	7.21e-05	0.000638	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PENK—Parkinson's disease	7.18e-05	0.000636	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MAG—Parkinson's disease	7.18e-05	0.000636	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	7.17e-05	0.000635	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—DRD3—Parkinson's disease	7.14e-05	0.000632	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—HTR7—Parkinson's disease	7.11e-05	0.000629	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—DRD2—Parkinson's disease	7.11e-05	0.000629	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—DRD3—Parkinson's disease	6.98e-05	0.000618	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—EDN1—Parkinson's disease	6.86e-05	0.000607	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GCH1—Parkinson's disease	6.84e-05	0.000605	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—HTR1A—Parkinson's disease	6.78e-05	0.0006	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GRM4—Parkinson's disease	6.73e-05	0.000596	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—TAC1—Parkinson's disease	6.67e-05	0.000591	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—ADRBK1—Parkinson's disease	6.66e-05	0.00059	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—PDYN—Parkinson's disease	6.57e-05	0.000582	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—DRD1—Parkinson's disease	6.54e-05	0.000579	CbGpPWpGaD
Midodrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	6.53e-05	0.000578	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.52e-05	0.000577	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—FGF20—Parkinson's disease	6.45e-05	0.000571	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—DRD2—Parkinson's disease	6.45e-05	0.000571	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—HTR7—Parkinson's disease	6.45e-05	0.000571	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PENK—Parkinson's disease	6.38e-05	0.000565	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MAG—Parkinson's disease	6.38e-05	0.000565	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—DRD3—Parkinson's disease	6.34e-05	0.000561	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—HTR7—Parkinson's disease	6.31e-05	0.000559	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—DRD2—Parkinson's disease	6.31e-05	0.000559	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ADORA2A—Parkinson's disease	6.26e-05	0.000554	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—EDN1—Parkinson's disease	6.23e-05	0.000551	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GFAP—Parkinson's disease	6.18e-05	0.000547	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—GRM5—Parkinson's disease	6.11e-05	0.000541	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—FBP1—Parkinson's disease	6.1e-05	0.00054	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—DBH—Parkinson's disease	6.1e-05	0.00054	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GBA—Parkinson's disease	6.1e-05	0.00054	CbGpPWpGaD
Midodrine—ADRA1D—GPCR downstream signaling—HTR2A—Parkinson's disease	6e-05	0.000531	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—ADRBK1—Parkinson's disease	5.92e-05	0.000524	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—PDYN—Parkinson's disease	5.84e-05	0.000517	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—INSR—Parkinson's disease	5.78e-05	0.000511	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—DRD2—Parkinson's disease	5.73e-05	0.000507	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—HTR7—Parkinson's disease	5.73e-05	0.000507	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—EDN1—Parkinson's disease	5.69e-05	0.000504	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GFAP—Parkinson's disease	5.49e-05	0.000486	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—FGB—Parkinson's disease	5.46e-05	0.000483	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—HTR2A—Parkinson's disease	5.45e-05	0.000482	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HTR1A—Parkinson's disease	5.43e-05	0.000481	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—GRM5—Parkinson's disease	5.43e-05	0.00048	CbGpPWpGaD
Midodrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	5.42e-05	0.00048	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FGF20—Parkinson's disease	5.36e-05	0.000474	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—TAC1—Parkinson's disease	5.35e-05	0.000473	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—DRD1—Parkinson's disease	5.24e-05	0.000464	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADORA2A—Parkinson's disease	5.19e-05	0.00046	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—EDN1—Parkinson's disease	5.17e-05	0.000457	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—DRD3—Parkinson's disease	5.08e-05	0.00045	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—EDN1—Parkinson's disease	5.05e-05	0.000447	CbGpPWpGaD
Midodrine—ADRA1B—GPCR downstream signaling—HTR2A—Parkinson's disease	4.98e-05	0.000441	CbGpPWpGaD
Midodrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	4.81e-05	0.000426	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—INSR—Parkinson's disease	4.79e-05	0.000424	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FGF20—Parkinson's disease	4.76e-05	0.000421	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—ADRBK1—Parkinson's disease	4.74e-05	0.00042	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADORA2A—Parkinson's disease	4.61e-05	0.000408	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—DRD2—Parkinson's disease	4.59e-05	0.000407	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HTR7—Parkinson's disease	4.59e-05	0.000407	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—EDN1—Parkinson's disease	4.59e-05	0.000406	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—FGB—Parkinson's disease	4.53e-05	0.000401	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—HTR2A—Parkinson's disease	4.52e-05	0.0004	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HTR1A—Parkinson's disease	4.51e-05	0.000399	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—DDC—Parkinson's disease	4.48e-05	0.000396	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—TAC1—Parkinson's disease	4.44e-05	0.000393	CbGpPWpGaD
Midodrine—ADRA1A—GPCR downstream signaling—HTR2A—Parkinson's disease	4.42e-05	0.000391	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—DRD1—Parkinson's disease	4.35e-05	0.000385	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—INSR—Parkinson's disease	4.26e-05	0.000377	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	4.23e-05	0.000374	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—DRD3—Parkinson's disease	4.22e-05	0.000373	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—FGB—Parkinson's disease	4.02e-05	0.000356	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—HTR2A—Parkinson's disease	4.01e-05	0.000355	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HTR1A—Parkinson's disease	4e-05	0.000354	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—TAC1—Parkinson's disease	3.94e-05	0.000349	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—ADRBK1—Parkinson's disease	3.94e-05	0.000348	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—DRD1—Parkinson's disease	3.87e-05	0.000342	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IGF2—Parkinson's disease	3.85e-05	0.000341	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HTR7—Parkinson's disease	3.81e-05	0.000337	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—DRD2—Parkinson's disease	3.81e-05	0.000337	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.81e-05	0.000337	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.77e-05	0.000333	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—DRD3—Parkinson's disease	3.74e-05	0.000331	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IGF1R—Parkinson's disease	3.72e-05	0.000329	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—EDN1—Parkinson's disease	3.68e-05	0.000325	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—ADRBK1—Parkinson's disease	3.5e-05	0.000309	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—DRD2—Parkinson's disease	3.39e-05	0.0003	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HTR7—Parkinson's disease	3.39e-05	0.0003	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—NGF—Parkinson's disease	3.38e-05	0.000299	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—HTR2A—Parkinson's disease	3.22e-05	0.000285	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IGF2—Parkinson's disease	3.19e-05	0.000283	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IGF1R—Parkinson's disease	3.09e-05	0.000273	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—EDN1—Parkinson's disease	3.05e-05	0.00027	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—APOE—Parkinson's disease	2.99e-05	0.000265	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IGF2—Parkinson's disease	2.84e-05	0.000251	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—NGF—Parkinson's disease	2.8e-05	0.000248	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.75e-05	0.000243	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IGF1R—Parkinson's disease	2.74e-05	0.000243	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—EDN1—Parkinson's disease	2.71e-05	0.00024	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—HTR2A—Parkinson's disease	2.67e-05	0.000236	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.56e-05	0.000227	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—INS—Parkinson's disease	2.56e-05	0.000226	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.53e-05	0.000224	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—TH—Parkinson's disease	2.5e-05	0.000221	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	2.49e-05	0.000221	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	2.48e-05	0.00022	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.4e-05	0.000212	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	2.37e-05	0.00021	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	2.2e-05	0.000195	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—COMT—Parkinson's disease	2.12e-05	0.000188	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—INS—Parkinson's disease	2.12e-05	0.000188	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.11e-05	0.000187	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.11e-05	0.000186	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.08e-05	0.000184	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	2e-05	0.000177	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.94e-05	0.000172	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—CASP3—Parkinson's disease	1.9e-05	0.000168	CbGpPWpGaD
Midodrine—ADRA1D—Signaling by GPCR—IL6—Parkinson's disease	1.89e-05	0.000167	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—INS—Parkinson's disease	1.88e-05	0.000167	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.86e-05	0.000164	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—MAPK8—Parkinson's disease	1.75e-05	0.000155	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.71e-05	0.000152	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—APOE—Parkinson's disease	1.6e-05	0.000141	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	1.58e-05	0.00014	CbGpPWpGaD
Midodrine—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	1.57e-05	0.000139	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	1.45e-05	0.000128	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	1.4e-05	0.000124	CbGpPWpGaD
Midodrine—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	1.39e-05	0.000123	CbGpPWpGaD
Midodrine—CYP2D6—Metabolism—INS—Parkinson's disease	1.36e-05	0.000121	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	1.29e-05	0.000114	CbGpPWpGaD
Midodrine—ADRA1D—Signaling Pathways—IL6—Parkinson's disease	1.12e-05	9.88e-05	CbGpPWpGaD
Midodrine—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	9.27e-06	8.2e-05	CbGpPWpGaD
Midodrine—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	8.23e-06	7.29e-05	CbGpPWpGaD
